This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the Effectiveness and Market Potential of Pfizer's (PFE) Crisaborole in Atopic Dermatitis After January 7th PDUFA Date

Ticker(s): PFE

Who's the expert?

A dermatologist or primary-care physician with significant experience treating patients with atopic dermatitis. He or she will be familiar with the data surrounding Crisaborole and other treatments in the market.

Interview Questions

Please describe your background and experience treating patients with atopic dermatitis. How many patients do you treat and what is your typical course of treatment? 

Added By: pjloria

How would you describe the efficacy and safety of current treatments? How do they compare to crisaborole in these areas? 

Added By: pjloria

Crisaborole topical ointment is a non-steroidal anti-inflammatory phosphodiesterase-4B inhibitor that contains a boron atom to help penetrate the skin. Can you discuss the effectiveness of this mechanism of action against atopic dermatitis? 

Added By: pjloria

How differentiated is this approach versus current treatment options? 

Added By: pjloria

The U.S market for atopic dermatitis is estimated at 18 million patients. What percentage of these patients are currently on treatment? 

Added By: pjloria

Are patients always receiving treatment, or do they only resort to prescriptions when their Eczema flares up? If they only get medication for flares how often does this occur? What are factors that lead to more "flare-ups"? 

Added By: pjloria

Assuming it is approved what percentage of patients do you think are a good fit to be treated with Crisaborole? 

Added By: pjloria

Are there any current treatment options, or any others being tested, that could be used in place of Crisaborole? What do you see being the dominant treatment in the market over the next two years assuming criaborole makes it to commercialization? 

Added By: pjloria

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.